The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months.
21 hours ago
0
73
Many serious pulmonary diseases, including genetic lung diseases, lack an effective treatment other than the most extreme: lung transplant. A team at Boston Children's Hospital envisions a much better option: cell therapy, ...
Jun 23, 2022
0
96
Researchers led by the Francis Crick Institute have found that blocking a particular protein could offer a new way to target leukemic stem cells without causing harm to healthy stem cells.
Jun 23, 2022
0
26
Hospitals across the country are teaming up to improve outcomes in kids who need mechanical heart pumps for congenital heart disease or heart failure.
Jun 23, 2022
0
49
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a novel drug molecule that targets T-cells causing inflammation in heart failure patients, stopping further progression ...
Jun 23, 2022
0
3
Six months ago, University of Maryland School of Medicine surgeon-scientists successfully implanted a genetically modified pig heart into a 57 year-old patient with terminal heart disease in a first-of-its-kind surgery. It ...
Jun 22, 2022
0
60
Among transplant-free survivors requiring predischarge reinterventions after congenital cardiac surgery, those with persistent major residua have significantly worse long-term outcomes, according to a study published in the ...
Jun 21, 2022
0
2
A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease. As part of the immune system, these cells have a protective function ...
Jun 21, 2022
0
44
No increase in pediatric hepatitis or adenovirus types 40/41 has been seen recently in the United States, according to research published in the June 14 early-release issue of the U.S. Centers for Disease Control and Prevention ...
Jun 16, 2022
0
3
Physicians at Stanford Medicine have developed a way to provide pediatric kidney transplants without immune-suppressing drugs. Their key innovation is a safe method to transplant the donor's immune system to the patient before ...
Jun 16, 2022
0
700
